Contact PI/Project LeaderGIORDANO, THOMAS P Other PIs
Awardee OrganizationBAYLOR COLLEGE OF MEDICINE
Description
Abstract Text
ABSTRACT
The Infection and Immunity NRSA post-doctoral training program based at Baylor College of Medicine (BCM)
has an outstanding record of training investigators at the cutting edge of research in infectious diseases and
immunity for the past 16 years. Trainees in the program will be at the postdoctoral level and a mixture of MDs
and PhDs each supported for 2 years for a total request of 3 stipends per year. This program is the sole NRSA
at BCM or the Texas Medical Center that supports the breadth of research training in infections and global
health, and one of very few programs in this region of the US. Superb training opportunities exist at BCM in a
number of areas. Participating faculty mentors have strong records of federal funding and training experience.
Areas of focus include: 1) enteric pathogens; 2) vaccine development and testing; 3) HIV; 4) tropical medicine
and public health; 5) bacterial pathobiology and treatment; 6) microbiome and functional genomics; and 7)
immunology. Total current grant support in for the projects participating in this NRSA Program is approximately
$52.9M. The Program offers three training tracks: 1) laboratory-based research, 2) patient-based research,
and 3) global and public health research. The Program Co-Directors are Thomas Giordano, MD, MPH, and
Mary Estes, PhD, who oversee and administer the program. Associate Program Director Robert Atmar, MD
and PeterHotez, MD, PhD, round out the Executive Committee. Selection of trainees is performed by the
Selection Committee, which includes the Executive Committee and three other program faculty. Excellent
training in translational team science is supported by the structure of the program. Both MD and PhD trainees
have a primary and co-mentor (one an MD and one a PhD), have an individual research advisory committee,
must prepare a written research proposal to be defended to the research committee, and have yearly reviews
that include academic and career assessment. Core training activities for all MD and PhD trainees include
developing an IDP, taking courses on clinical investigation, grants and contracts, and human subjects
research; participating in team science and career development seminars; and attending a monthly research-
in-progress seminar series, a weekly journal club, and a yearly scientific retreat. All trainees must present at
these meetings. The Adult and Pediatric Infectious Diseases Training Programs at BCM and other
Departments participating in this NRSA have shown they can attract highly qualified, training-grant eligible
postdoctoral trainee candidates including underrepresented minority candidates. Twenty-two trainees have
completed training supported by this award to date; all but one remain in a research or research-related career.
These graduates have been awarded a total of $7.9M in external federal funding. Forty four percent of the
trainees appointed in the last funding period are members of underrepresented minority populations. The
program is a critical pipeline for researchers and academicians in the US South and continuation of the
program at three slots per year is warranted.
Public Health Relevance Statement
PROJECT NARRATIVE
The persistent threat to health posed by infectious diseases mandates that the United States continue to train
a diverse and sophisticated cadre of biomedical investigators with the research and clinical skills necessary to
develop and implement new strategies to diagnose, prevent and treat them. This NRSA has successfully
accomplished these training objectives and holds great promise to continue along this vital path.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
051113330
UEI
FXKMA43NTV21
Project Start Date
01-August-2003
Project End Date
30-June-2025
Budget Start Date
01-August-2020
Budget End Date
30-June-2021
Project Funding Information for 2020
Total Funding
$219,499
Direct Costs
$241,938
Indirect Costs
$17,915
Year
Funding IC
FY Total Cost by IC
2020
National Institute of Allergy and Infectious Diseases
$219,499
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2T32AI055413-16A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2T32AI055413-16A1
Patents
No Patents information available for 2T32AI055413-16A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2T32AI055413-16A1
Clinical Studies
No Clinical Studies information available for 2T32AI055413-16A1
News and More
Related News Releases
No news release information available for 2T32AI055413-16A1
History
No Historical information available for 2T32AI055413-16A1
Similar Projects
No Similar Projects information available for 2T32AI055413-16A1